DUOX2 Mutations Are Frequently Associated With Congenital Hypothyroidism in the Korean Population.
10.3343/alm.2016.36.2.145
- Author:
Kyoung Jin PARK
1
;
Hyun Kyung PARK
;
Young Jin KIM
;
Kyoung Ryul LEE
;
Jong Ho PARK
;
June Hee PARK
;
Hyung Doo PARK
;
Soo Youn LEE
;
Jong Won KIM
Author Information
1. Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, Seoul, Korea. kimjw@skku.edu
- Publication Type:Original Article ; Research Support, Non-U.S. Gov't
- Keywords:
Congenital hypothyroidism;
Newborn screening;
Incidence;
Mutation;
DUOX2
- MeSH:
Asian Continental Ancestry Group/*genetics;
Child;
Child, Preschool;
Congenital Hypothyroidism/epidemiology/*genetics/pathology;
Exons;
Female;
Genetic Association Studies;
Genotype;
Humans;
Infant;
Infant, Newborn;
Male;
NADPH Oxidase/*genetics;
Polymorphism, Single Nucleotide;
Republic of Korea/epidemiology;
Sequence Analysis, DNA;
Thyrotropin/blood
- From:Annals of Laboratory Medicine
2016;36(2):145-153
- CountryRepublic of Korea
- Language:English
-
Abstract:
BACKGROUND: Most cases with congenital hypothyroidism (CH) are usually sporadic, while about 20% of the cases are caused by genetic defects. Little information is available regarding the mutation incidence and genetic heterogeneity of CH in Koreans. We aimed to determine the mutation incidence of CH in newborn screenings (NBS) and to evaluate the frequency and spectrum of mutations underlying CH. METHODS: A total of 112 newborns with thyroid dysfunction were enrolled from 256,624 consecutive NBS. Furthermore, 58 outpatients with primary CH were added from an endocrine clinic. All coding exons of TSHR, PAX8, TPO, DUOX2, DUOXA2, and SCL5A5 were sequenced. RESULTS: The mutation incidence of CH was estimated to be 1 in 6,580 newborns. A total of 36 different mutations were identified in 53 cases. The overall mutation positive rate was 31%. The DUOX2 mutations were the most prevalent in both newborns and outpatients. Seven different recurrent mutations [p.G488R (n=13), p.A649E (n=3), p.R885Q (n=3), p.I1080T (n=2), and p.A1206T (n=2) in DUOX2; p.Y138X (n=9) in DUOXA2; and p.R450H (n=5) in TSHR) were identified as the mutations underlying CH. CONCLUSIONS: The mutation incidence of CH was considerably higher than expected in the Korean newborn population. This study revealed seven different recurrent mutations underlying CH. We conclude that DUOX2 mutations are a frequent cause of CH in the Korean population.
